Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

about

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.

P2860

Q47140684-EE9B46DC-DC97-44F4-B747-85899183DDBB

P2860

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

Item

http://www.wikidata.org/entity/Q37453940

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@en

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@nl

type

Item

label

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@en

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@nl

prefLabel

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@en

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@nl

P1476

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

@en

P2093

Emma Ivansson

http://www.w3.org/2001/XMLSchema#string

Fuat Celebioglu

http://www.w3.org/2001/XMLSchema#string

Gustaf Rosin

http://www.w3.org/2001/XMLSchema#string

Irma Fredriksson

http://www.w3.org/2001/XMLSchema#string

Jan Frisell

http://www.w3.org/2001/XMLSchema#string

Jonas Bergh

http://www.w3.org/2001/XMLSchema#string

Lorand Kis

http://www.w3.org/2001/XMLSchema#string

Mattias Rantalainen

http://www.w3.org/2001/XMLSchema#string

P2860

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

Activating HER2 mutations in HER2 gene amplification negative breast cancer

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Repeated observation of breast tumor subtypes in independent gene expression data sets

Regularization Paths for Generalized Linear Models via Coordinate Descent

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Diagnosis of multiple cancer types by shrunken centroids of gene expression

P2888

srep38037

P304

38037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP38037

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034845288

http://www.w3.org/2001/XMLSchema#string

P698

27901097

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5128815

http://www.w3.org/2001/XMLSchema#string

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

about

P2860

P2860

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P921

P932